Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, Palos Verdes, Calif.
Rocky Mountain Poison and Drug Center, Denver Health and Hospital Authority, Denver, Colo.
Acad Pediatr. 2018 Jul;18(5):563-568. doi: 10.1016/j.acap.2018.03.001. Epub 2018 Mar 6.
To assess the impact of the 2011 changes in pediatric single-ingredient liquid acetaminophen product packaging and standardization of the acetaminophen concentration (160 mg/5 mL) on poison control center exposures due to medication errors.
National Poison Data System (NPDS) data from January 1, 2007, through December 31, 2016, were used to identify medication error exposures involving single-ingredient liquid acetaminophen in children younger than 12 years of age. Surveys were conducted through 6 regional poison control centers to obtain additional information on a subset of exposures.
The annual frequency of NPDS exposures due to medication errors with single-ingredient liquid acetaminophen products was 8260 ± 670 exposures/year during 2007-2011. Children <2 years of age accounted for 66% of exposures. The overall rate of exposures fell to 6669 ± 662 during 2012-2016 (19% decrease; P = .005). Four percent of exposures led to health care facility referrals. Caregivers involved with exposures in children <2 years of age cited health professionals as the source of dosing information in only 69% of cases despite the absence of specific dosing directions for these children on product labels.
Implementation of a single concentration for pediatric liquid acetaminophen products and packaging changes were associated with a decrease in medication errors reported to poison control centers. Medication errors are particularly problematic for children <2 years of age, for whom there are no specific labeled dosing instructions. Improved efforts to provide caregivers with dosing instructions for these children are encouraged.
评估 2011 年儿科单一成分液体对乙酰氨基酚产品包装变化和对乙酰氨基酚浓度标准化(160mg/5mL)对因用药错误导致中毒控制中心暴露的影响。
使用 2007 年 1 月 1 日至 2016 年 12 月 31 日国家毒物数据系统(NPDS)的数据,确定 12 岁以下儿童因单一成分液体对乙酰氨基酚用药错误导致的暴露情况。通过 6 个地区中毒控制中心进行调查,以获取部分暴露情况的附加信息。
2007-2011 年,因单一成分液体对乙酰氨基酚产品用药错误导致 NPDS 暴露的年频率为 8260±670 次/年。暴露者中<2 岁的儿童占 66%。2012-2016 年,总体暴露率降至 6669±662 次(下降 19%;P=0.005)。4%的暴露导致医疗保健机构转介。尽管产品标签上没有针对这些儿童的具体剂量说明,但<2 岁儿童的照顾者在 69%的情况下仅将卫生专业人员作为剂量信息的来源。
实施儿科液体对乙酰氨基酚产品单一浓度和包装变化与向中毒控制中心报告的用药错误减少相关。用药错误对<2 岁的儿童尤其成问题,因为这些儿童的标签上没有具体的剂量说明。鼓励加强为这些儿童提供剂量说明的努力。